Oxford COVID-19 vaccine final trials will be held in these 17 hospitals in India
A total of 1,600 candidates will take part in the study
King Edward Memorial Hospital Parel, and BYL Nair Hospitals, Mumbai Central — have received approval from ICMR to start the trial
The phase II and phase III clinical trial of COVID-19 vaccine developed by the University of Oxford is all set to start in India. Indian pharmaceutical major Serum Institute of India has initiated the process, according to report by news agency ANI.